Digitalni repozitorij raziskovalnih organizacij Slovenije

Iskanje po repozitoriju
A+ | A- | Pomoč | SLO | ENG

Iskalni niz: išči po
išči po
išči po
išči po

Možnosti:
  Ponastavi


Iskalni niz: "avtor" (Primož Strojan) .

1 - 10 / 142
Na začetekNa prejšnjo stran12345678910Na naslednjo stranNa konec
1.
2.
The incidence and the risk factors for pharyngocutaneous fistula following primary and salvage total laryngectomy
Robert Šifrer, Primož Strojan, Ivana Tancer, Maja Dolenc, Simon Fugina, Sara Bitenc, Aleksandar Aničin, 2023, izvirni znanstveni članek

Povzetek: The pharyngocutaneous fistula (PCF) is the most common complication following a total laryngectomy (TL) with a wide range of incidence and various potential risk factors. The aim was to analyse the incidence and potential risk factors for PCF formation in a large study set collected over a longer period of time. In the retrospective study at the Department of Otorhinolaryngology and Cervicofacial Surgery of Ljubljana, 422 patients who were treated for head and neck cancer by TL between 2007 and 2020 were included. The comprehensive clinicopathologic data were collected including potential risk factors related to the patient, disease, surgical treatment and post-operative period for the development of fistulae. The patients were categorized into a group with the fistula (a study group) and one without it (a control group). The PCF then developed in 23.9% of patients. The incidence following a primary TL was 20.8% and 32.7% following salvage TL (p = 0.012). The results demonstrated that surgical wound infection, piriform sinus invasion, salvage TL, and total radiation dose were determined as independent risk factors for PCF formation. A diminishing surgical wound infection rate would contribute to a further reduction of the PCF rate.
Ključne besede: chemoradiotherapy, dose of radiotherapy, fistula
Objavljeno v DiRROS: 06.08.2026; Ogledov: 24; Prenosov: 14
.pdf Celotno besedilo (263,48 KB)
Gradivo ima več datotek! Več...

3.
Strokovna priporočila za obravnavo radiodermatitisa in radiomukozitisa
Sandra Gole, Martina Goličnik, Vesna Jašić, Andreja Klinc, Januša Marenk, Irena Oblak, Miha Oražem, Klemen Schara, Primož Strojan, Petra Šanc, Maja Trošt, Bernarda Ugovšek, 2026, strokovni članek

Povzetek: Radioterapija predstavlja pomemben del sodobnega onkološkega zdravljenja, vendar pogosto povzroča neželene učinke na koži in sluznicah, med katerimi sta najpogostejša radiodermatitis in radiomukozitis. Namen strokovnih priporočil je poenotiti obravnavo bolnikov, izboljšati prepoznavanje zgodnjih sprememb ter podati priporočila za preprečevanje, ocenjevanje in zdravljenje teh zapletov. Dokument obravnava etiologijo, dejavnike tveganja, klinično sliko in stopnje radiodermatitisa ter radiomukozitisa glede na področje obsevanja. Poseben poudarek je namenjen preventivnim ukrepom, zdravstveni negi, prehranski podpori, obvladovanju bolečine ter multidisciplinarnemu pristopu pri obravnavi bolnikov med in po zdravljenju z radioterapijo. Priporočila so namenjena zdravstvenim delavcem in sodelavcem na vseh ravneh zdravstvenega varstva, ki sodelujejo pri vsakodnevni oskrbi onkoloških bolnikov
Ključne besede: radioterapija, radiodermatitis, radiomukozitis, onkološka zdravstvena nega, neželeni učinki zdravljenja
Objavljeno v DiRROS: 31.07.2026; Ogledov: 70; Prenosov: 25
.pdf Celotno besedilo (464,77 KB)

4.
5.
Clinical characteristics and outcomes of tympanomastoid paragangliomas : a report from Slovenia
Manja Hribar, Iztok Fošnarič, Aleš Matos, Robert Šifrer, Aleš Grošelj, Maruša Debeljak, Nina Zidar, Primož Strojan, Klemen Jenko, 2024, izvirni znanstveni članek

Povzetek: Background: Head and neck paragangliomas are neuroendocrine tumors that typically originate from the parasympathetic nervous system and are predominantly non-secretory. Their clinical manifestations result from their mass effect on the surrounding tissues. The approach to treating these tumors depends on factors such as their location, size, impact on adjacent structures, and the patient’s overall health and preferences. (2) Methods: A retrospective analysis of the management of temporal bone paraganglioma classes A and B (according to the modified Fisch classification) was performed at the University Medical Centre, Ljubljana, between 2011 and 2023. (3) Results: We analyzed 23 cases, 19 of which underwent surgery; complete tumor removal was achieved in 18 of them. Four patients were irradiated due to tumor progression to class C. Three of these four patients initially refused surgery and were treated with radiotherapy (RT) 7, 13, and 18 years after diagnosis. In the fourth patient, complete surgical resection was not achieved and she was treated with RT four years after surgery, due to the growth of the tumor to class C. The average follow-up time from diagnosis was 8.9 years (median 6 years; range 1–26 years). (4) Conclusions: The surgical treatment of patients with class A and B paragangliomas is effective and safe. In cases where surgery is refused but the tumor continues to grow to class C, RT is an alternative and efficient method of controlling tumor growth.
Ključne besede: paraganglioma, jugulotympanic, tympanic, treatment
Objavljeno v DiRROS: 04.06.2026; Ogledov: 248; Prenosov: 177
.pdf Celotno besedilo (6,93 MB)
Gradivo ima več datotek! Več...

6.
Radioterapija : klinična realnost danes, vizija čez desetletje
Primož Strojan, 2026, objavljeni strokovni prispevek na konferenci

Povzetek: Razvoj radioterapije poganja hiter napredek na področjih tehnologije, umetne inteligence in razumevanja tumorske biologije. Temeljni cilj stroke ostaja nespremenjen: uničenje tumorskih celic ob maksimalni zaščiti zdravih tkiv. Ključna razvojna področja vključujejo izboljšano opredelitev tarčnega volumna, zmanjšanje obsevanja zdravih tkiv, povečanje terapevtske učinkovitosti ter optimizacijo kombiniranih načinov zdravljenja. V zadnjem desetletju so pomemben napredek omogočili MR-vodeni sistemi, adaptivna radioterapija, avtomatizacija postopkov ter širša uporaba protonske terapije in stereotaktičnih tehnik. Vzporedno z razvojem sistemske imunoterapije in njenimi uspehi tudi v radioterapiji v ospredje prihaja vloga imunskega sistema, saj radioterapija poleg citotoksičnega učinka deluje tudi imunomodulatorno. Ker lahko poškodbe imunskega sistema zmanjšajo učinkovitost zdravljenja, sodobni razvojni pristopi stremijo k njegovemu ohranjanju. Med najobetavnejše radioterapevtske tehnologije sodijo FLASH, protonska terapija in prostorsko frakcionirana radioterapija (SFRT), ki omogočajo ugodnejše razmerje med citotoksičnostjo in zaščito imunskega sistema. V prihodnjem desetletju pričakujemo nadaljnji razvoj teh tehnologij ter poglobljeno razumevanje interakcij med ionizirajočim sevanjem in imunskim odzivom.
Ključne besede: onkologija, radioterapija, obvladovanje raka
Objavljeno v DiRROS: 03.06.2026; Ogledov: 151; Prenosov: 73
.pdf Celotno besedilo (280,41 KB)

7.
8.
9.
Human papillomavirus-related oropharyngeal squamous cell carcinoma exhibits enhanced radiosensitivity despite limited activation of cytosolic DNA sensing pathways and innate immune responses
Kristina Levpušček, Tanja Jesenko, Tilen Komel, Simona Kranjc Brezar, Gregor Serša, Maja Čemažar, Primož Strojan, 2025, izvirni znanstveni članek

Povzetek: Pharyngeal squamous cell carcinoma (PSCC) is a significant health concern, with human papillomavirus 16 (HPV16) playing a key role in the etiology of oropharyngeal squamous cell carcinoma (OPSCC). HPV16-related OPSCC exhibits enhanced radiosensitivity compared to HPV16-unrelated PSCC, yet the underlying mechanisms remain poorly understood. As HPV16 oncoproteins E6 and E7 are known to interfere with innate immune signaling, we investigated how modulation of cytosolic DNA sensing pathways and innate immune responses changes after irradiation (IR) and whether this contributes to enhanced radiosensitivity in HPV16-related OPSCC. Materials and methods Using HPV16-related and -unrelated PSCC models, we examined baseline expression levels of DNA sensors and cytokines and assessed the effects of IR on double-stranded DNA (dsDNA) accumulation, activation of cytosolic DNA sensors, cytokines, and immune cell infiltration both in vitro and in vivo. Analyses were performed using real-time quantitative polymerase chain reaction (RT-qPCR) and immunofluorescent staining. Results HPV16-related OPSCC exhibited a distinct baseline expression profile of DNA sensors and cytokines, consistent with suppression of the stimulator of interferon genes (STING) pathway. While IR-induced activation of DNA sensors was dose- and time-dependent across models, HPV16-related OPSCC showed selective activation of cyclic GMP-AMP synthase (cGAS) and STING without significant cytokine upregulation or immune activation. In contrast, HPV16-related and unrelated PSCCs displayed activation of multiple DNA sensors, increased cytokine expression, and enhanced immune cell infiltration following IR. Conclusions The key finding was that the involvement of cytosolic DNA sensing pathways and innate immune system do not increase radiosensitivity of HPV16-related OPSCC. In PSCC models, DNA sensor and cytokine expression varied depending on IR dose and fractionation.
Ključne besede: human papillomavirus, oropharyngeal squamous cell carcinoma, radiosensitivity
Objavljeno v DiRROS: 16.01.2026; Ogledov: 445; Prenosov: 208
.pdf Celotno besedilo (1,41 MB)

10.
Induction chemotherapy and concurrent chemoradiotherapy for larynx preservation in laryngeal and hypopharyngeal cancer
Primož Strojan, Gaber Plavc, Robert Šifrer, Simona Jereb, Boštjan Lanišnik, Marko Kokalj, Aleš Grošelj, Cvetka Grašič-Kuhar, 2025, izvirni znanstveni članek

Povzetek: To test the hypothesis that clinical tumor response after a single cycle of induction chemotherapy (ICT) can reliably differentiate between chemo-/radiosensitive and resistant tumors in the larynx preservation setting. Patients and methods Treatment consisted of docetaxel/cisplatin/5-fluorouracil (TPF) ICT followed by concurrent chemoradiotherapy (cCRT) with weekly cisplatin. The response of the primary tumor was assessed by transnasal endoscopy after the first ICT cycle. Results 37/39 (95%) patients with laryngeal (46%) or hypopharyngeal (54%) carcinoma responded to one cycle of ICT, and two patients were referred for salvage surgery. Laryngectomy-free survival at 2 and 5 years was 87% and 75%, respectively. The corresponding rates for locoregional control (and also for disease-free survival) were 79% and 70% and for overall survival 92% and 82%. Conclusions Clinical assessment of tumor response to one cycle of TPF ICT serves as a valid and easy-to-use predictor of tumor sensitivity to platinum-based cCRT.
Ključne besede: induction chemotherapy, chemoradiotherapy, arynx preservation
Objavljeno v DiRROS: 16.01.2026; Ogledov: 504; Prenosov: 646
.pdf Celotno besedilo (883,77 KB)
Gradivo ima več datotek! Več...

Iskanje izvedeno v 0.28 sek.
Na vrh